How should insulin be dosed in an NBM (nothing by mouth) patient with HbA1c (glycated hemoglobin) of 10% and random blood glucose (RBS) of 400 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Management in NBM Patient with HbA1c 10% and RBS 400 mg/dL

For an NBM (nothing by mouth) patient with severe hyperglycemia (HbA1c 10%, RBS 400 mg/dL), initiate basal insulin ONLY at 0.5 U/kg/day given as a single daily dose, plus correctional insulin every 4-6 hours using rapid-acting insulin analogs. Do NOT give prandial insulin since the patient is not eating.

Initial Insulin Dosing Algorithm

Step 1: Calculate Total Daily Dose (TDD)

For this patient with RBS 400 mg/dL (within the 201-400 mg/dL range) and HbA1c >10%, start with 0.5 U/kg/day 1. This represents the upper end of the recommended range given the severe hyperglycemia.

Important caveat: Reduce to 0.2-0.3 U/kg/day if the patient is:

  • Age ≥70 years
  • GFR <60 mL/min
  • Frail or malnourished 1

Step 2: Distribute the Insulin Dose

Since the patient is NBM:

  • 100% of TDD = Basal insulin (glargine once daily or detemir/NPH twice daily)
  • 0% prandial insulin (hold completely - patient not eating) 1

For example, in a 70 kg patient without contraindications:

  • TDD = 70 kg × 0.5 U/kg = 35 units
  • Give 35 units of basal insulin (glargine once daily at same time each day, OR detemir/NPH 17-18 units twice daily)

Step 3: Add Correctional (Supplemental) Insulin

Critical for NBM patients: Add correctional doses using the "insulin-sensitive" or "usual" column depending on patient factors 1:

  • Rapid-acting insulin analog: Every 4-6 hours
  • Regular insulin: Every 6 hours (at 6-12-6-12 schedule)

Use the insulin-sensitive column for:

  • Elderly patients
  • Those not eating
  • Impaired renal function 1

Correctional Scale (from Endocrine Society Guidelines):

Blood Glucose (mg/dL) Insulin-Sensitive Usual Insulin-Resistant
141-180 2 units 4 units 6 units
181-220 4 units 6 units 8 units
221-260 6 units 8 units 10 units
261-300 8 units 10 units 12 units
301-350 10 units 12 units 14 units
351-400 12 units 14 units 16 units
≥400 14 units 16 units 18 units

For your patient with RBS 400 mg/dL, start with 14 units (insulin-sensitive) or 16 units (usual) of rapid-acting insulin immediately 1.

Ongoing Management

Monitoring Schedule

  • Check blood glucose every 4-6 hours (before scheduled correctional doses)
  • Adjust basal insulin based on fasting/morning glucose trends
  • Continue correctional insulin at each check 1

Titration Strategy

For persistent hyperglycemia (≥2 readings ≥180 mg/dL in 24 hours):

  • Increase basal insulin by 10-20% every 1-3 days
  • If requiring >24 units of correctional insulin in 24 hours, add that total to the next day's basal dose 1, 2

For hypoglycemia:

  • BG <70 mg/dL: Reduce basal by 10-20%
  • BG <40 mg/dL: Reduce basal by 20-40% 3

Critical Pitfalls to Avoid

  1. Never use sliding-scale insulin (SSI) alone - this results in 3-fold increased risk of hyperglycemia >200 mg/dL and poor outcomes 1

  2. Do NOT give prandial insulin to NBM patients - this causes severe hypoglycemia. Only basal + correctional insulin 1

  3. If patient starts eating: Immediately restart prandial insulin at 50% of original TDD divided into three pre-meal doses, while continuing basal insulin 1

  4. Discontinue oral diabetes medications on admission - they are contraindicated in acute illness and NBM status 1

  5. Watch for glucose toxicity resolution - as hyperglycemia improves over days, insulin requirements may DROP significantly, requiring dose reductions to prevent hypoglycemia 3

When to Intensify

The severe hyperglycemia (HbA1c >10%, BG ≥300 mg/dL) indicates glucose toxicity that requires prompt reduction 3. If basal + correctional insulin fails to achieve BG <180 mg/dL within 24-48 hours, consider:

  • Increasing basal insulin more aggressively (by 20% daily)
  • Consulting endocrinology for possible insulin infusion if critically ill 3

Once eating resumes: Transition to full basal-bolus regimen with 50% basal and 50% prandial (divided into three pre-meal doses), maintaining correctional insulin at all times 1.

References

Guideline

american association of clinical endocrinology consensus statement: comprehensive type 2 diabetes management algorithm - 2023 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2023

Related Questions

For a female patient weighing 43 kg with a hemoglobin A1c of 13 % and normal renal function who is started on insulin glargine (100 units/mL), how many milliliters of insulin should be administered, how often should it be given each day, and which oral antidiabetic agents should be added?
Can Total Daily Dose (TDD) of insulin be calculated daily based on basal, bolus, and correction doses to adjust new basal and bolus dosing for hospitalized patients with impaired glucose control?
For a 59-year-old, 123‑kg man with type 2 diabetes (creatinine 0.84 mg/dL, eGFR > 90 mL/min) currently on U‑500 regular insulin (115 U at breakfast, 115 U at lunch, 50 U at dinner) and receiving dexamethasone 10 mg at 16:00 and 6 mg at 14:30, what NPH (intermediate‑acting) insulin dose should be added and how should the U‑500 insulin doses be adjusted?
What are the recommended timings for basal and rapid‑acting insulin doses in a 70‑kg adult?
What is the best approach to manage elevated fasting glucose levels in a patient with diabetes who is currently taking Lantus (insulin glargine)?
How should a patient taking duloxetine (Cymbalta) 30 mg be switched to vortioxetine (Trintellix), including the appropriate starting dose and transition protocol?
Does creatine supplementation cause any hormonal effects?
What essential questions should be asked when evaluating a middle‑aged or older adult for possible trigeminal neuralgia?
What are the clinical implications of air‑fluid levels throughout the bowel on an abdominal X‑ray when there is no significant small‑bowel dilatation?
Which ulcerative colitis biologic is also approved for treatment of rheumatoid arthritis?
Can an otolaryngologist (ENT) perform an upper endoscopy (esophagogastroduodenoscopy)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.